164 related articles for article (PubMed ID: 11359656)
1. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.
Chen YM; Tsai CM; Whang-Peng J; Perng RP
J Interferon Cytokine Res; 2001 Apr; 21(4):249-56. PubMed ID: 11359656
[TBL] [Abstract][Full Text] [Related]
2. Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.
Chen YM; Tsai CM; Whang-Peng J; Perng RP
Chest; 2002 Oct; 122(4):1421-7. PubMed ID: 12377874
[TBL] [Abstract][Full Text] [Related]
3. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
4. Additive effect of Interleukin-12 and Interleukin-18 on the T-helper cell pathway of malignant pleural effusion.
Yao NS; Chen YM; Perng RP; Whang-Peng J
Lung; 2002; 180(1):15-24. PubMed ID: 12105753
[TBL] [Abstract][Full Text] [Related]
5. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
6. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 stimulation activates mesothelial cellular functioning against autologous tumor cells.
Chen YM; Hsieh YL; Tsai CM; Perng RP
J Chin Med Assoc; 2004 Jul; 67(7):323-30. PubMed ID: 15510928
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion.
Hiraki A; Aoe K; Matsuo K; Murakami K; Murakami T; Onoda T; Sugi K; Takeyama H; Eda R
Int J Tuberc Lung Dis; 2003 Dec; 7(12):1172-7. PubMed ID: 14677892
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions.
Ibrahim L; Salah M; Abd El Rahman A; Zeidan A; Ragb M
Immunol Invest; 2013; 42(2):122-36. PubMed ID: 23252864
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.
Okamoto M; Kawabe T; Iwasaki Y; Hara T; Hashimoto N; Imaizumi K; Hasegawa Y; Shimokata K
J Lab Clin Med; 2005 Feb; 145(2):88-93. PubMed ID: 15746651
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of IL-7 and IL-12 on human T cell activation.
Mehrotra PT; Grant AJ; Siegel JP
J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.
Chen YM; Yang WK; Whang-Peng J; Tsai WY; Hung YM; Yang DM; Lin WC; Perng RP; Ting CC
J Immunother; 1997 Sep; 20(5):354-64. PubMed ID: 9336742
[TBL] [Abstract][Full Text] [Related]
13. Elevation of interleukin-10 levels in malignant pleural effusion.
Chen YM; Yang WK; Whang-Peng J; Kuo BI; Perng RP
Chest; 1996 Aug; 110(2):433-6. PubMed ID: 8697847
[TBL] [Abstract][Full Text] [Related]
14. Infiltration of interleukin-2-inducible killer cells in ascitic fluid and pleural effusions of advanced cancer patients.
Blanchard DK; Kavanagh JJ; Sinkovics JG; Cavanagh D; Hewitt SM; Djeu JY
Cancer Res; 1988 Nov; 48(22):6321-7. PubMed ID: 2972357
[TBL] [Abstract][Full Text] [Related]
15. [Determination and significance of interleukin-16 in tuberculous and malignant pleural effusion].
Huang ZX; Shi HZ; Kang LF; Qin XJ; Mo WN; Chen YQ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):199-201. PubMed ID: 16624150
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
17. Analysis of immunologic mechanisms of high natural killer cell activity in tuberculous pleural effusions.
Ota T; Okubo Y; Sekiguchi M
Am Rev Respir Dis; 1990 Jul; 142(1):29-33. PubMed ID: 2114810
[TBL] [Abstract][Full Text] [Related]
18. Activation of Valpha24NKT cells in malignant pleural effusion in patients with lung cancer.
Shimizu T; Takahashi N; Terakado M; Tsujino I; Hashimoto S
Oncol Rep; 2009 Sep; 22(3):581-6. PubMed ID: 19639207
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th2 cytokine profiles in malignant pleural effusion.
Ghayumi MA; Mojtahedi Z; Fattahi MJ
Iran J Immunol; 2011 Dec; 8(4):195-200. PubMed ID: 22201616
[TBL] [Abstract][Full Text] [Related]
20. Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma.
Ebihara T; Koyama S
Tohoku J Exp Med; 1990 Sep; 162(1):49-63. PubMed ID: 2077678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
